scholarly journals Rhinovirus Infections (RhVI) in 233 Hematopoietic Cell Transplant (HCT) Recipients: A Single Center Experience

2016 ◽  
Vol 3 (suppl_1) ◽  
Author(s):  
Mahnaz Taremi ◽  
Dimpy Shah ◽  
Danielle El-Haddad ◽  
Firas El Chaer ◽  
Lynn El Haddad ◽  
...  
Keyword(s):  
Hematopoietic Cell ◽  
Cell Transplant ◽  
Single Center ◽  
Hematopoietic Cell Transplant ◽  
Single Center Experience

scholarly journals Hematopoietic Cell Transplant for Patients With NEMO Defect: A Single Center Experience

2013 ◽  
Vol 19 (2) ◽  
pp. S244
Author(s):  
Shanmuganathan Chandrakasan ◽  
Jack Bleesing ◽  
Denise Bellman ◽  
Rebecca A. Marsh ◽  
Stella Davies ◽  
...  
Keyword(s):  
Hematopoietic Cell ◽  
Cell Transplant ◽  
Single Center ◽  
Hematopoietic Cell Transplant ◽  
Single Center Experience

scholarly journals Outcome of Hematopoietic Cell Transplant for Hemophagocytic Lymphohistiocytosis in Adults: A Single Center Experience

2013 ◽  
Vol 19 (2) ◽  
pp. S284 ◽  
Author(s):  
Shanmuganathan Chandrakasan ◽  
Rebecca A. Marsh ◽  
Denise Bellman ◽  
Michael Grimley ◽  
Jack Bleesing ◽  
...  
Keyword(s):  
Hemophagocytic Lymphohistiocytosis ◽  
Hematopoietic Cell ◽  
Cell Transplant ◽  
Single Center ◽  
Hematopoietic Cell Transplant ◽  
Single Center Experience

Allogeneic hematopoietic cell transplant for relapsed-refractory, marginal zone lymphoma: a single-center experience

2018 ◽  
Vol 59 (11) ◽  
pp. 2727-2730 ◽  
Author(s):  
Bhagirathbhai R. Dholaria ◽  
William A. Hammond ◽  
Vivek Roy ◽  
Taimur Sher ◽  
Prakash Vishnu ◽  
...  
Keyword(s):  
Marginal Zone ◽  
Marginal Zone Lymphoma ◽  
Hematopoietic Cell ◽  
Cell Transplant ◽  
Single Center ◽  
Hematopoietic Cell Transplant ◽  
Allogeneic Hematopoietic Cell Transplant ◽  
Single Center Experience

scholarly journals COVID‐19 post hematopoietic cell transplant, a report of 11 cases from a single center.

2020 ◽  
Vol 12 (1) ◽  
pp. e2020070 ◽  
Author(s):  
Afadil Adam
Keyword(s):  
Mechanical Ventilation ◽  
Cancer Patients ◽  
Hematopoietic Cell ◽  
Cell Transplant ◽  
Single Center ◽  
Sars Coronavirus ◽  
Oxygen Supplementation ◽  
Hematopoietic Cell Transplant ◽  
Presenting Symptoms ◽  
Complicated Course

In late 2019 the coronavirus disease‐2019 (COVID‐19) pandemic caused by SARS Coronavirus 2 (SARS‐CoV‐2) started in Wuhan, China. Cancer patients are immunosuppressed from their disease and the therapy they receive.Hematopoietic cell transplant (HCT) recipients are a subgroup of patients that are severely immunocompromised and may be at an even higher risk of a complicated course during this infection.We herein report the outcomes and course of 11 sequential cases of HCT recipients infected by SARS‐CoV‐2 treated in our center.The patients age ranged from 17 to 60 years, the duration from transplant to infection ranged from day +5 to 192 months, 6 patients were post allo-HCT, 4 post auto-HCT and one had both allo and auto-HCT. The presenting symptoms were not different from other viral illnesses. The majority had mild COVID-19 stage, while 3 had moderate stage on presentation. None of the patients required oxygen supplementation nor mechanical ventilation.

Sign in / Sign up

Export Citation Format

Share Document